Related Experiment Videos

Early onset MS under the age of 16: clinical and paraclinical features

E Sindern1, J Haas, E Stark

  • 1Department of Neurology with Clinical Neurophysiology, Medical School Hannover, Germany.

Insights

Multiple sclerosis (MS) in juvenile patients under 16 mirrors adult disease clinically. However, specific symptoms and diagnostic markers like oligoclonal bands are key in pediatric MS.

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Immunology

Background:

  • Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • Juvenile-onset MS (JOMS) presents unique diagnostic and clinical considerations.
  • Understanding JOMS is crucial for early intervention and management.

Purpose of the Study:

  • To compare the clinical presentation and disease course of MS in juvenile patients (<16 years) versus adult-onset MS.
  • To identify characteristic features and diagnostic markers specific to JOMS.

Main Methods:

  • Retrospective analysis of 620 MS patients diagnosed between 1975-1991.
  • Comparison of clinical data, including onset symptoms, disease course, relapse rates, and cerebrospinal fluid (CSF) and MRI findings, between juvenile (n=31) and adult-onset (n=72) MS cohorts.

Main Results:

  • JOMS (5% of population) showed no significant clinical differences from adult-onset MS in terms of onset symptoms, progression, or relapse rates.
  • Characteristic initial symptoms in some juvenile patients included fever, headache, nausea, vomiting, and CSF pleocytosis.
  • Oligoclonal bands in CSF and MRI findings were identified as valuable diagnostic tools for JOMS.

Conclusions:

  • Juvenile-onset MS shares clinical similarities with adult-onset MS.
  • Specific initial symptoms and the presence of oligoclonal bands are important indicators for diagnosing MS in pediatric patients.
  • Cerebrospinal fluid and MRI are highly valuable for diagnosing JOMS.

Related Concept Videos